Treating Neuroendocrine Prostate Cancer
William K. Oh, MD, explores neuroendocrine prostate cancer, emphasizing its increasing prevalence and aggressive nature.
Read MoreSelect Page
Posted by William K. Oh, MD | Apr 2025
William K. Oh, MD, explores neuroendocrine prostate cancer, emphasizing its increasing prevalence and aggressive nature.
Read MorePosted by Siamak Daneshmand, MD | Apr 2025
Siamak Daneshmand, MD, covers recent updates in bladder cancer guidelines, focusing on the 2024 NCCN and AUA recommendations.
Read MorePosted by Katherine Amin, MD | Apr 2025
Katherine Amin, MD, focuses on care for pelvic floor disorders among minority women, addressing disparities in treatment and access.
Read MorePosted by Michael A. Gorin, MD | Apr 2025
Michael A. Gorin, MD, shares his transperineal prostate biopsy procedure under local anesthesia in the office setting.
Read MorePosted by Arthur L. Burnett II, MD, MBA, FACS | Apr 2025
Arthur L. Burnett II, MD, MBA, FACS, explores intraoperative neuromonitoring in radical prostatectomy.
Read More